100sek
-1,3 %
Date:2025-05-16Time:18:00:00Latest report:Q1-2025List:Small CapTicker:KDEV
Market Cap:270 msekEnterprise Value:221 msekNet Sales:1,90 msekEarnings:-22,5 msekEmployees:0ISIN:SE0002190926

Ratios

10-year key figure history for Karolinska Development turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Karolinska Development with index and moving average MA50 and MA200.

Stockprice:1,00
MA50:0,95
MA200:1,10
Price/MA200:-9,3 %
RSI (14):62,8
Price/MA50:5,2 %

Description

Karolinska Development is an investment company focused on long-term equity investments in biotechnology and pharmaceutical companies. The company's goal is to develop promising medical innovations stemming from academic research at Karolinska Institutet and other universities in the Nordic region. The company's portfolio includes companies in sectors such as biotechnology and medical technology. Karolinska Development was founded in 2003 and is headquartered in Solna, Sweden.

Holding Companies